L.I.A. Pure Capital Ltd. Increases Stake in Clearmind Medicine Inc. to 5.0%

L.I.A. Pure Capital Ltd. has acquired a 5.0% stake in Clearmind Medicine Inc. The total number of shares beneficially owned by L.I.A. Pure Capital Ltd. is 108,720. This ownership includes 20,470 common shares directly held, 93,231 common shares issuable upon conversion of a convertible promissory note, and 229,000 common shares potentially acquirable through the exercise of a pre-funded warrant. The ownership percentage is based on 2,088,806 common shares outstanding as of the reporting date. The filing indicates that these securities were not acquired for the purpose of changing or influencing the control of the issuer.